{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:42:53Z","timestamp":1777502573097,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072798"],"award-info":[{"award-number":["82072798"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373900"],"award-info":[{"award-number":["82373900"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073873"],"award-info":[{"award-number":["82073873"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bbrc.2025.152883","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T16:20:04Z","timestamp":1761668404000},"page":"152883","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Mechanistic insights into pharmacokinetic interactions between simvastatin and vismodegib: Implications for optimization of combination therapy in medulloblastoma"],"prefix":"10.1016","volume":"791","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-4092-861X","authenticated-orcid":false,"given":"Chaonan","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zining","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4315-0319","authenticated-orcid":false,"given":"Wanjun","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9296-0911","authenticated-orcid":false,"given":"Chunshan","family":"Gui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5084-0804","authenticated-orcid":false,"given":"Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuechu","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2025.152883_bib1","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/jnr.23917","article-title":"Medulloblastoma initiation and spread: where neurodevelopment, microenvironment and cancer cross pathways","volume":"94","author":"Martirosian","year":"2016","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbrc.2025.152883_bib2","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/nrc3410","article-title":"Medulloblastomics: the end of the beginning","volume":"12","author":"Northcott","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2025.152883_bib3","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1586\/ern.12.66","article-title":"Molecular subgroups of medulloblastoma","volume":"12","author":"Northcott","year":"2012","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.bbrc.2025.152883_bib4","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/ng0996-78","article-title":"The role of the human homologue of drosophila patched in sporadic basal cell carcinomas","volume":"14","author":"Gailani","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrc.2025.152883_bib5","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0092-8674(00)81268-4","article-title":"Mutations of the human homolog of drosophila patched in the nevoid basal cell carcinoma syndrome","volume":"85","author":"Hahn","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2025.152883_bib6","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1073\/pnas.0611682104","article-title":"Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma","volume":"104","author":"Peacock","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2025.152883_bib7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4291\/wjgp.v7.i2.199","article-title":"Differential role of Hedgehog signaling in human pancreatic (patho-) physiology: an up to date review","volume":"7","author":"Klieser","year":"2016","journal-title":"World J. Gastrointest. Pathophysiol."},{"key":"10.1016\/j.bbrc.2025.152883_bib8","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.surg.2005.10.012","article-title":"Sonic Hedgehog-dependent proliferation in a series of patients with colorectal cancer","volume":"139","author":"Douard","year":"2006","journal-title":"Surgery"},{"key":"10.1016\/j.bbrc.2025.152883_bib9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ccr.2008.01.027","article-title":"Transient inhibition of the Hedgehog pathway in young mice causes permanent defects in bone structure","volume":"13","author":"Kimura","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2025.152883_bib10","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/neuonc\/nox109","article-title":"Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma","volume":"19","author":"Kieran","year":"2017","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.bbrc.2025.152883_bib11","doi-asserted-by":"crossref","first-page":"69295","DOI":"10.18632\/oncotarget.20619","article-title":"Irreversible growth plate fusions in children with medulloblastoma treated with a targeted hedgehog pathway inhibitor","volume":"8","author":"Robinson","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2025.152883_bib12","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1158\/1078-0432.CCR-13-1425","article-title":"Phase I study of vismodegib in children with recurrent or refractory medulloblastoma: a pediatric brain tumor consortium study","volume":"19","author":"Gajjar","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2025.152883_bib13","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jdcr.2020.04.029","article-title":"Rare bone toxicity associated with vismodegib","volume":"6","author":"Ciciarelli","year":"2020","journal-title":"JAAD Case Rep."},{"key":"10.1016\/j.bbrc.2025.152883_bib14","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1126\/science.1179386","article-title":"Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma","volume":"326","author":"Yauch","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2025.152883_bib15","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1158\/0008-5472.CAN-10-2876","article-title":"Small molecule inhibition of GDC-0449 refractory smoothened mutants and downstream mechanisms of drug resistance","volume":"71","author":"Dijkgraaf","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2025.152883_bib16","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.molonc.2014.09.003","article-title":"Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma","volume":"9","author":"Pricl","year":"2015","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bbrc.2025.152883_bib17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13578-022-00828-0","article-title":"Lipid metabolism and storage in neuroglia: role in brain development and neurodegenerative diseases","volume":"12","author":"Yang","year":"2022","journal-title":"Cell Biosci."},{"key":"10.1016\/j.bbrc.2025.152883_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11020146","article-title":"Cholesterol metabolism: a potential therapeutic target in glioblastoma","volume":"11","author":"Ahmad","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbrc.2025.152883_bib19","doi-asserted-by":"crossref","first-page":"14037","DOI":"10.1074\/jbc.273.22.14037","article-title":"Identification of a palmitic acid-modified form of human Sonic hedgehog","volume":"273","author":"Pepinsky","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2025.152883_bib20","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.coph.2012.07.002","article-title":"Cholesterol and its derivatives in Sonic Hedgehog signaling and cancer","volume":"12","author":"Riobo","year":"2012","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.152883_bib21","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/s41586-019-1355-4","article-title":"Smoothened stimulation by membrane sterols drives Hedgehog pathway activity","volume":"571","author":"Deshpande","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2025.152883_bib22","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.molcel.2017.02.015","article-title":"Cholesterol modification of Smoothened is required for hedgehog signaling","volume":"66","author":"Xiao","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbrc.2025.152883_bib23","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41422-022-00622-0","article-title":"Cholesterylation of Smoothened is a calcium-accelerated autoreaction involving an intramolecular ester intermediate","volume":"32","author":"Hu","year":"2022","journal-title":"Cell Res."},{"key":"10.1016\/j.bbrc.2025.152883_bib24","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1158\/1078-0432.CCR-17-2923","article-title":"Statins synergize with Hedgehog pathway inhibitors for treatment of medulloblastoma","volume":"24","author":"Gordon","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2025.152883_bib25","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1038\/s41388-021-01701-z","article-title":"Statins repress hedgehog signaling in medulloblastoma with no bone toxicities","volume":"40","author":"Fan","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2025.152883_bib26","doi-asserted-by":"crossref","first-page":"850","DOI":"10.3109\/00498250903180289","article-title":"Preclinical assessment of the absorption, distribution, metabolism and excretion of GDC-0449 (2-chloro-N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-(methylsulfonyl)benzamide), an orally bioavailable systemic Hedgehog signalling pathway inhibitor","volume":"39","author":"Wong","year":"2009","journal-title":"Xenobiotica"},{"key":"10.1016\/j.bbrc.2025.152883_bib27","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0090-9556(25)07595-6","article-title":"Metabolic disposition studies on simvastatin, a cholesterol-lowering prodrug","volume":"18","author":"Vickers","year":"1990","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbrc.2025.152883_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ph16030380","article-title":"A Study on pharmacokinetic functionalities and safety margins of an optimized Simvastatin nanoformulation","volume":"16","author":"Ahmad","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bbrc.2025.152883_bib29","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1124\/dmd.121.000406","article-title":"Comparative hepatic and intestinal metabolism and pharmacodynamics of statins","volume":"49","author":"Filppula","year":"2021","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbrc.2025.152883_bib30","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/FPC.0000000000000079","article-title":"CYP3A4\u221722 and CYP3A5\u22173 are associated with increased levels of plasma simvastatin concentrations in the cholesterol and pharmacogenetics study cohort","volume":"24","author":"Kitzmiller","year":"2014","journal-title":"Pharmacogenet. Genom."},{"key":"10.1016\/j.bbrc.2025.152883_bib31","first-page":"1191","article-title":"In vitro metabolism of simvastatin in humans [SBT]identification of metabolizing enzymes and effect of the drug on hepatic P450s","volume":"25","author":"Prueksaritanont","year":"1997","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbrc.2025.152883_bib32","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.1365-2125.2003.01833.x","article-title":"The human hepatic metabolism of simvastatin hydroxy acid is mediated primarily by CYP3A, and not CYP2D6","volume":"56","author":"Prueksaritanont","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.152883_bib33","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1124\/dmd.104.002477","article-title":"Differential interaction of 3-hydroxy-3-methylglutaryl-coa reductase inhibitors with ABCB1, ABCC2, and OATP1B1","volume":"33","author":"Chen","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbrc.2025.152883_bib34","doi-asserted-by":"crossref","DOI":"10.1093\/omcr\/omx104","article-title":"Statin-induced rhabdomyolysis: a complication of a commonly overlooked drug interaction","volume":"2018","author":"Ezad","year":"2018","journal-title":"Oxf. Med. Case. Reports."},{"key":"10.1016\/j.bbrc.2025.152883_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2020.183210","article-title":"Investigation of the interactions between flavonoids and human organic anion transporting polypeptide 1B1 using fluorescent substrate and 3D-QSAR analysis","volume":"1862","author":"Xiang","year":"2020","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.bbrc.2025.152883_bib36","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1124\/jpet.104.067793","article-title":"Metabolism of thalidomide in liver microsomes of mice, rabbits, and humans","volume":"310","author":"Lu","year":"2004","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.bbrc.2025.152883_bib37","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bbrc.2025.152883_bib38","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1021\/acs.molpharmaceut.7b00957","article-title":"Inhibition of human CYP3A4 by rationally designed Ritonavir-Like compounds: impact and Interplay of the Side Group functionalities","volume":"15","author":"Samuels","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bbrc.2025.152883_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.108484","article-title":"Cyclosporine A sterically inhibits statin transport by solute carrier OATP1B1","volume":"301","author":"Sung","year":"2025","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2025.152883_bib40","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1021\/ct900018t","article-title":"Reduced catalytic activity of P450 2A6 mutants with coumarin: a computational investigation","volume":"5","author":"Li","year":"2009","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.bbrc.2025.152883_bib41","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1358\/mf.2002.24.9.802312","article-title":"Preclinical pharmacokinetics of statins","volume":"24","author":"Reinoso","year":"2002","journal-title":"Methods Find Exp. Clin. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.152883_bib42","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1124\/dmd.106.012930","article-title":"Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3","volume":"35","author":"No\u00e9","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbrc.2025.152883_bib43","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/bdd.749","article-title":"Inhibitory effects of ketoconazole and rifampin on OAT1 and OATP1B1 transport activities: considerations on drug-drug interactions","volume":"32","author":"Choi","year":"2011","journal-title":"Biopharm Drug Dispos."},{"key":"10.1016\/j.bbrc.2025.152883_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/separations9120400","article-title":"Simvastatin: in vitro metabolic profiling of a potent competitive HMG-CoA reductase inhibitor","volume":"9","author":"Yin","year":"2022","journal-title":"Separations"},{"key":"10.1016\/j.bbrc.2025.152883_bib45","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1124\/dmd.30.3.225","article-title":"Structural characterization of in vivo rat glutathione adducts and a hydroxylated metabolite of simvastatin hydroxy acid","volume":"30","author":"Subramanian","year":"2002","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbrc.2025.152883_bib46","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1124\/dmd.110.032680","article-title":"Interplay of dissolution, solubility, and nonsink permeation determines the oral absorption of the Hedgehog pathway inhibitor GDC-0449 in dogs: an investigation using preclinical studies and physiologically based pharmacokinetic modeling","volume":"38","author":"Wong","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbrc.2025.152883_bib47","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1124\/dmd.112.048397","article-title":"Carboxylesterases are uniquely expressed among tissues and regulated by nuclear hormone receptors in the mouse","volume":"41","author":"Jones","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbrc.2025.152883_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.05.029","article-title":"Simvastatin inhibits the proliferation of HL-60 clone 15- derived eosinophils by inducing the arrest of the cell cycle in the G1\/S phase","volume":"856","author":"Fu","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.152883_bib49","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13046-020-01723-7","article-title":"Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition","volume":"39","author":"Iannelli","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2025.152883_bib50","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/febs.15069","article-title":"Simvastatin increases temozolomide-induced cell death by targeting the fusion of autophagosomes and lysosomes","volume":"287","author":"Shojaei","year":"2020","journal-title":"FEBS J."},{"key":"10.1016\/j.bbrc.2025.152883_bib51","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3109\/00498254.2016.1159747","article-title":"Epigallocatechin-3-gallate decreases the transport and metabolism of simvastatin in rats","volume":"47","author":"Yang","year":"2017","journal-title":"Xenobiotica"},{"key":"10.1016\/j.bbrc.2025.152883_bib52","doi-asserted-by":"crossref","first-page":"286","DOI":"10.7326\/0003-4819-149-4-200808190-00019","article-title":"The effect of green tea on simvastatin tolerability","volume":"149","author":"Werba","year":"2008","journal-title":"Ann. Intern. Med."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25015992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25015992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:19:16Z","timestamp":1777389556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25015992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":52,"alternative-id":["S0006291X25015992"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152883","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanistic insights into pharmacokinetic interactions between simvastatin and vismodegib: Implications for optimization of combination therapy in medulloblastoma","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152883","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152883"}}